Podcasts about barouch

Jonathan Barouch, CEO of Local Measure, joins us to discuss their journey of leading and innovating through a major business disruption.Topics Include:Intro to Local MeasureThe pre-Covid business model and customersImpact of CovidLosing 75% of their revenue within monthsTeams navigating the early months of CovidReinventing the businessTesting, iterating new business modelsLeveraging AWS APIs for Amazon Connect Cloud Contact Center solutionBalancing the former focus and contact centre pivotThe importance of a call centre in lean timesMigrating call centres of airlines and banks within 30 daysChange management and the Local Measure solutionLeveraging AI/ML for additional customer efficienciesShaving seconds off calls equate to huge savingsLeveraging AI/ML to turbocharge agentsAdditional industries for the Local Measure solutionTransforming data for tangible benefitProactive, predictive and outbound engagementsGuidance for other Software Executives going through disruptionWhat's next for Local MeasureInterview wrap up

Olivier Levy-Barouch, directeur général adjoint de La Banque Postale en charge de la direction finance et stratégie, et Marc Tempelman, cofondateur et président de Cashbee, étaient les invités de Frédéric Simottel dans Tech & Co, ce jeudi 23 juin. Ils sont revenus sur la stratégie d'innovation de la Banque Postale, sur BFM Business. Retrouvez l'émission du lundi au jeudi et réécoutez la en podcast.

We catch up with Dr. Barouch, the director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center.

Jonathan Barouch is the founder and Chief Executive Officer of Local Measure. Local Measure is a customer experience platform for the hospitality, tourism, retail, and entertainment industries allowing businesses to receive real-time customer intelligence whenever customers are on-premise, helping them to identify, understand and retain customers.

Presentazione di Cristiana Santoni

In this episode, we meet Jonathan Barouch, serial entrepreneur and the founder and CEO of Local Measure. Jonathan was also the founder of fastflowers.com.au one of Australia's first e-commerce companies and is an ambassador for the Sydney Story Factory. www.chiefmaker.com/184 We talk all about: What he learned from his early days starting, growing and selling one of Australia's first e-commerce companies What most companies get wrong in measuring customer service How technology has helped transform the way we measure and engage with customer in real-time The importance of aligning technology and culture How employee experience is following the same path What the best leaders are doing right now to lead through the crisis

On Meet the Press, an exclusive joint interview with Dr. Peter Hotez, Director, Texas Children’s Hospital Center for Vaccine Development and Dr. Dan Barouch, Director, Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center. Gov. Mike DeWine (R-Ohio) talks to Chuck Todd about the importance of masks, during an exclusive interview. National Security Adviser Robert O’Brien says China is risking sanctions by pushing for more control over Hong Kong. Andrea Mitchell, O. Kay Henderson and Jeh Johnson join the Meet the Press roundtable.

Finally! Finally, thanks to Local measure's Jonathan Barouch, we're all going to discover how to create an incredible customer experience that will make it easier to do business with us, infinitely more enjoyable and crazily shareable. It's a highly experiential episode 486 of The (award-winning) Small Business Big Marketing Show thanks to American Express.   A little bit more about Local Measure's Jonathan Barouch … Marketing is full of jargon, right? And probably the most bandied around term of recent years has been customer experience, or CX as those in the know like to call it. But what is it? Why's it important? How can it help grow my business? And if it can, how do I get some of that action? All excellent questions, which are about to be answered by customer experience expert Jonathan Barouch, who is the founder of real-time customer intelligence company Local Measure .... and is also one of Australia's most respected tech entrepreneurs. Local Measure is next generation customer experience (mainly in the hospitality, travel & tourism sectors), providing highly-targeted, real-time customer intelligence, insight and demographic info to businesses about their customers. So if the idea of wowing those precious customers of yours appeals, then grab a pen and paper (I know, how old school!) and get ready to be wowed yourself. I started off by asking Jonathan to share the best customer experience he'd ever had.   “It's so much easier for a small business to deliver an incredible customer experience than it is for a big one.”    - Jonathan Barouch, Local Measure   Here's what caught my attention from my chat with Local Measure's Jonathan Barouch: I love the idea of giving deep consideration to the end-to-end journey of the customer as they travel through your business, the whole time asking yourself “How do I want my customer to feel?” I love that Jonathan acknowledges that B2B and B2C are just a distraction from the real way of doing business which is H2H (human-to-human) or P2P as I like to call it … people-to-people.  Be mindful of the fact that every customer now has a megaphone and more and more are willing to use it, thanks to social media, Google Reviews, and other review sites. So actively seek good reviews and testimonials, and be sure to respond to the good and bad ones.   “We need to start looking at our customers more holistically … from every angle …. And all the way along the purchase cycle.”    - Jonathan Barouch, Local Measure   Resources mentioned in episode 486 of The Small Business Big Marketing Show: Local Measure's official website Great customer experience case studies on the Local Measure website Last week's interview with rockstar Lachy Doley on how to make it big in the cut-throat music industry Interviews I've done about customer experience: Jay Baer on how to deal with customer complaints Joshua Nichols on his 21-step customer manifesto Zappo's Jenn Lim on delivering happiness   This week's Monster Prize Draw winner Peter Braid of Braid & Co   Please support the following businesses who make this show possible:   American Express Business Explorer Credit Card Let your business expenses reward you. Every year.   Switchnode Australia's Internet isn't great. That's why Switchnode exist. The solution is here and it's wireless.   If something in this episode of Australia's favourite marketing podcast peaked your interest, then let me know by leaving a comment below. May your marketing be the best marketing. [ For more interviews with successful business owners visit Small Business Big Marketing ] See omnystudio.com/listener for privacy information.

Why have scientists struggled to generate a protective HIV vaccine? Dan Barouch lays out the unique challenges and discusses the ongoing clinical trial with an adenovirus-based vaccine developed in his lab. Julie’s Biggest Takeaways HIV poses unique and unprecedented challenges for vaccine development including: Viral diversity: extremely wide range of viral diversity. No natural precedent: No human has cleared HIV based on their immune responses. Unknown correlates of protection: scientists are unsure what immune responses are important to induce. Barouch’s group uses a vaccine strategy comprised of computationally optimized mosaic HIV Env proteins, which represent pieces of the outermost glycoprotein, Env, that have been tied together in a way expected to generate protective immunity. Early data from animal and human trials suggests these mosaic antigens generate an immune response to a wider array of HIV types than previous vaccines. Clinical trials are ongoing to see if a strategy of mosaic antigen vaccination, followed by a boost with Env protein, is protective in people. Attenuated HIV hasn’t been used as a vaccine strategy because of fears it could revert to a disease-causing form; similar fears have prevented a whole-killed virus platform for vaccine development. A clinical trial testing safety in 3 locations around the world demonstrated that this vaccine strategy in people elicited immune responses shown to be protective in animals. An efficacy trial is ongoing in sub-Saharan Africa, with results expected in 2021. The trial is double blinded: neither the doctor nor the patient know who was administered the candidate vaccine or who was administered the placebo. HIV latent infection causes complications in vaccine development because HIV latency is seeded early, possibly in the first few days of infection. Once latency is established, the individual is infected for life. Any low level of HIV infection in vaccinated people could potentially seed this latent infection. Quickly-seeded latency means immune responses must react extremely quickly. Featured Quotes “The challenges in the development of a prophylactic HIV vaccine are among the toughest challenges in biomedical and scientific research.” “HIV poses unique challenges for vaccine development and truly unprecedented challenges that have never been posed before by vaccination. One such challenge is the viral diversity: HIV exists not as a single sequence, but as numerous different viral sequences — not only throughout the world, but also throughout regions, communities, and even within the same individual. So to create a vaccine against HIV, the immune responses have to be relevant for a vast diversity of viral sequences.” “At what efficacy level would an HIV vaccine be licenced by both the industry partners as well as the government regulators in a particular country, and at what level of efficacy would it actually have a major public health impact? It’s a moving target over time; it really depends on what the current state of the epidemic is at the time the vaccine is ready to be licensed.” “It’s critical to have high-quality research part of the clinical efficacy trials so that success or failure or something in between, that the HIV research field learns from it, and learns what worked well and what didn’t work well, and how to make better vaccines moving forward.” “I always encourage young scientists to pursue their dreams and to tackle hard problems. There’s a lot of easy problems to solve but some of the hardest problems are the most impactful in the end.” Links for This Episode MTM Listener Survey Barouch lab at the Center for Virology and Vaccine Research. MTM: Mark Connors. The Lancet: Evaluation of a Mosaic HIV-1 Vaccine in a Multicentre, Randomised, Double-Blide, Placebo-Controlled, Phase 1/2 a Clinical Trial (APPROACH) and in Rhesus Monkeys. The Lancet: A Step Forward for HIV Vaccines. Journal of Virology: Similar Epitope Specificities of IgG and IgA Antibodies Elicited by Ad26 Vector Prime, Env Protein Boost Immunizations in Rhesus Monkeys. PLoS One: First-in-Human Randomized, Controlled Trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1. HOM Tidbit: I am the Berlin Patient: A Personal Reflection. HOM Tidbit: Doctor who cured Berlin Patient of HIV: ‘We knew we were doing something very special’.

Is it over commercialized? Yes. What's the point. Top 10 worst fathers day gifts. Hashtags and gary's favorite gift.

In the pre-production stages of the video podcasts. Tips & tricks riffs & sticks. I'll be discussing all things drums. From rudiments to drum set techniques. Thank you to Vic Firth & Zildjian for supplying me with the tools I need to pull this off. Subscribe now.

Dr. Dan Barouch is the Director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center and Harvard Medical School and a Program Leader at the Reagan Institute of Massachusetts General Hospital, MIT, and Harvard University. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. D.H. Barouch. The Quest for an HIV-1 Vaccine - Moving Forward. N Engl J Med 2013;369:2073-6.

Jonathan Barouch talks about LocalMeasure

Here's a quick sample of some latin stuff

Just getting a drum check in the studio, nothing fancy. I've been working on my sound. It's getting better. Just waiting for some tracks to show up via FTP.

Orr Barouch, Midfielder, Chicago Fire, joins the show to discuss the Fire's pre-season and how the team is shaping up for the new MLS season.

This is my 1982 solo.